BR0303080A - Seleção de marcadores - Google Patents
Seleção de marcadoresInfo
- Publication number
- BR0303080A BR0303080A BR0303080-6A BR0303080A BR0303080A BR 0303080 A BR0303080 A BR 0303080A BR 0303080 A BR0303080 A BR 0303080A BR 0303080 A BR0303080 A BR 0303080A
- Authority
- BR
- Brazil
- Prior art keywords
- parameters
- measure
- diagnostic
- selecting
- relationship
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108700026220 vif Genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Complex Calculations (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36879002P | 2002-03-29 | 2002-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0303080A true BR0303080A (pt) | 2004-02-17 |
Family
ID=27805329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0303080-6A BR0303080A (pt) | 2002-03-29 | 2003-03-28 | Seleção de marcadores |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20030194734A1 (enExample) |
| EP (1) | EP1349104A3 (enExample) |
| JP (1) | JP2004163388A (enExample) |
| KR (1) | KR20030078803A (enExample) |
| CN (1) | CN1495272A (enExample) |
| AR (1) | AR039212A1 (enExample) |
| AU (1) | AU2003203529A1 (enExample) |
| BR (1) | BR0303080A (enExample) |
| CA (1) | CA2422309A1 (enExample) |
| MX (1) | MXPA03002865A (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1361433A3 (en) * | 2002-04-09 | 2005-02-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method for estimating therapeutic efficacy of tumor necrosis factor (TNF) |
| US20040191782A1 (en) * | 2003-03-31 | 2004-09-30 | Yixin Wang | Colorectal cancer prognostics |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| US20090081645A1 (en) * | 2004-08-02 | 2009-03-26 | Hidehito Kotani | Method of assuming drug sensitivity to cdk4 inhibitor |
| WO2006060653A2 (en) * | 2004-11-30 | 2006-06-08 | Veridex Llc | Lung cancer prognostics |
| KR100690250B1 (ko) * | 2005-01-31 | 2007-03-12 | 디지탈 지노믹스(주) | 폐암 진단용 마커 |
| WO2006080597A1 (en) * | 2005-01-31 | 2006-08-03 | Digital Genomics Inc. | Markers for the diagnosis of lung cancer |
| US20070037186A1 (en) | 2005-05-20 | 2007-02-15 | Yuqiu Jiang | Thyroid fine needle aspiration molecular assay |
| IL177006A0 (en) | 2005-08-02 | 2006-12-10 | Veridex Llc | Predicting bone relapse of breast cancer |
| US20070130694A1 (en) * | 2005-12-12 | 2007-06-14 | Michaels Emily W | Textile surface modification composition |
| US20070207467A1 (en) | 2006-03-01 | 2007-09-06 | Ming Xu | Detection of lymph node metastasis from gastric carcinoma |
| WO2008045133A2 (en) * | 2006-03-03 | 2008-04-17 | Veridex, Llc | Molecular assay to predict recurrence of dukes' b colon cancer |
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| SG144111A1 (en) * | 2006-12-22 | 2008-07-29 | Shares Advisors Llc X | Portfolio selection for custom indices of public securities based on state of domicile of issuing company |
| EP2114990B9 (en) | 2007-02-27 | 2012-03-28 | Nuclea Biomarkers LLC | Method for predicting the response of NSCLC-patients to treatment by an EGFR-TK inhibitor |
| CN101960022A (zh) * | 2008-01-22 | 2011-01-26 | 维里德克斯有限责任公司 | Ⅱ期和ⅲ期结肠癌的分子分期和预后 |
| EP2271775A4 (en) | 2008-04-08 | 2011-09-07 | Nuclea Biomarkers Llc | BIOMARKERGROUP FOR PREDICTING THE REPRESENTATION OF COLORECTAL CARCINOMA |
| CA2725978A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| EP2350320A4 (en) | 2008-11-12 | 2012-11-14 | Caris Life Sciences Luxembourg Holdings | METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| US9206482B2 (en) | 2009-04-29 | 2015-12-08 | Genomedx Biosciences Inc. | Systems and methods for expression-based classification of thyroid tissue |
| EP3360978A3 (en) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| AU2011223789A1 (en) | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| EP2791359B1 (en) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| ES3015226T3 (en) | 2012-08-16 | 2025-04-30 | Veracyte Sd Inc | Prostate cancer prognosis using biomarkers |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| CN114606309A (zh) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | 使用机器学习和高维转录数据的诊断系统和方法 |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| WO2018132916A1 (en) | 2017-01-20 | 2018-07-26 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| AU2018230784A1 (en) | 2017-03-09 | 2019-10-10 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| WO2018205035A1 (en) | 2017-05-12 | 2018-11-15 | Genomedx Biosciences, Inc | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| US20250384974A1 (en) * | 2024-06-18 | 2025-12-18 | Unlearn.AI, Inc. | Systems and Methods for Optimizing Composite Scores |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1000347B (el) * | 1988-12-21 | 1992-06-25 | Ortho Diagnostic Systems Inc | Μεθοδος παραγωγης νουκλεοτιδικων ανιχνευτων χρησιμοποιωντας ενα συμπληρωμα γεφυρωσεως. |
| US6350576B1 (en) * | 1994-12-20 | 2002-02-26 | Cold Spring Harbor Laboratory | Cancer detection probes |
| US5972614A (en) * | 1995-12-06 | 1999-10-26 | Genaissance Pharmaceuticals | Genome anthologies for harvesting gene variants |
| US6275814B1 (en) * | 1996-11-27 | 2001-08-14 | Investment Strategies Network | Investment portfolio selection system and method |
| US6003018A (en) * | 1998-03-27 | 1999-12-14 | Michaud Partners Llp | Portfolio optimization by means of resampled efficient frontiers |
| US6401043B1 (en) * | 1999-04-26 | 2002-06-04 | Variagenics, Inc. | Variance scanning method for identifying gene sequence variances |
| US6714925B1 (en) * | 1999-05-01 | 2004-03-30 | Barnhill Technologies, Llc | System for identifying patterns in biological data using a distributed network |
| US6175824B1 (en) * | 1999-07-14 | 2001-01-16 | Chi Research, Inc. | Method and apparatus for choosing a stock portfolio, based on patent indicators |
| KR20020092891A (ko) * | 1999-07-15 | 2002-12-12 | 리서치 디벨럽먼트 파운데이션 | 코르티코트로핀 분비 인자 수용체 2 결핍 마우스 및 이의용도 |
-
2003
- 2003-03-21 US US10/394,087 patent/US20030194734A1/en not_active Abandoned
- 2003-03-28 CA CA002422309A patent/CA2422309A1/en not_active Abandoned
- 2003-03-28 BR BR0303080-6A patent/BR0303080A/pt not_active IP Right Cessation
- 2003-03-28 AU AU2003203529A patent/AU2003203529A1/en not_active Abandoned
- 2003-03-29 CN CNA031312047A patent/CN1495272A/zh active Pending
- 2003-03-29 KR KR10-2003-0019839A patent/KR20030078803A/ko not_active Withdrawn
- 2003-03-31 JP JP2003095679A patent/JP2004163388A/ja active Pending
- 2003-03-31 MX MXPA03002865A patent/MXPA03002865A/es unknown
- 2003-03-31 EP EP03252027A patent/EP1349104A3/en not_active Withdrawn
- 2003-04-01 AR ARP030101133A patent/AR039212A1/es not_active Application Discontinuation
-
2009
- 2009-07-01 US US12/496,399 patent/US20100009371A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AR039212A1 (es) | 2005-02-09 |
| EP1349104A3 (en) | 2004-01-02 |
| US20100009371A1 (en) | 2010-01-14 |
| CN1495272A (zh) | 2004-05-12 |
| CA2422309A1 (en) | 2003-09-29 |
| KR20030078803A (ko) | 2003-10-08 |
| AU2003203529A1 (en) | 2003-10-23 |
| US20030194734A1 (en) | 2003-10-16 |
| MXPA03002865A (es) | 2004-08-11 |
| EP1349104A2 (en) | 2003-10-01 |
| JP2004163388A (ja) | 2004-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0411743A (pt) | método e composições para tratar doenças relacionadas a amilóides | |
| AR039212A1 (es) | Metodos de seleccion de porfolios de marcadores para uso en aplicaciones de diagnostico, maquinas para identificar porfolios de marcadores, articulos que comprenden instrucciones para seleccionar dichos porfolios ,y porfolios de diagnosticos seleccionados por dichos metodos | |
| BR0309546A (pt) | Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii | |
| BRPI0407734A (pt) | derivados de adamantano, processo para sua preparação e composições farmacêuticas os contendo | |
| BR0212809A (pt) | Inibidores de anticorpos de gdf-8 e usos dos mesmos | |
| CA2417500A1 (en) | Erbb-2 selective small molecule kinase inhibitors | |
| IL171343A (en) | Compound 1, 2, 4 - Oxadiazole Benzoic Acid, a pharmaceutical composition containing it, a method for testing the compound, and its use in the preparation of a drug for the treatment of early-onset disease before the end codon | |
| BR0214805A (pt) | Lama viscosa de alta perda de fluido solúvel em ácido para circulação perdida | |
| BR0207332A (pt) | Composição de fluido de fraturamento hidráulico, e, processo para gerar fissuras em uma formação subterrânea | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| AU2002255093A1 (en) | Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye | |
| TW200505423A (en) | Combination, kit and pharmaceutical composition for treatment of parkinson's disease | |
| BRPI0415760A (pt) | derivados de benzimidazolila | |
| WO2004007743A3 (en) | Use of cpg nucleic acids in prion-disease | |
| BR0114199A (pt) | Sequências de nucleotìdeos que medeiam a fertilidade masculina e métodos de uso das mesmas | |
| BRPI0416156A (pt) | uso de tienopirimidinas | |
| BRPI0801078A2 (pt) | processo para relaxar ou alisar os cabelos | |
| BRPI0410149A (pt) | métodos para determinar caracterìsticas de formação e para determinar compactação de formação | |
| BRPI0417732A (pt) | aplicação de gene amilóide a sérico no diagnóstico e tratamento do glaucoma e identificação de agentes antiglaucoma | |
| AR030554A1 (es) | Moleculas similares a receptores il-17 y usos de las mismas | |
| WO2003105773A3 (en) | Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: | |
| BR0308055A (pt) | Processo para a preparação de compostos de azo catiÈnicos | |
| BR0303912A (pt) | Composição para o condicionamento, composição para o condicionamento durável, método para o condicionamento, método para o condicionamento durável, método para o cuidado ou tratamento e kit para o cuidado, tratamento, condicionamento ou condicionamento durável | |
| BRPI0407031A (pt) | Composições e métodos para tratamento de câncer empregando igsf9 e liv-1 | |
| EP1572225A4 (en) | THROMBOSPONDIN FRAGMENTS AND THEIR USE IN CLINICAL CANCER TESTS AND THE PRODUCTION OF ANTIBODIES AND OTHER BINDING AGENTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2042 DE 23/02/2010. |